MedTrace Logo

Therapeutic Option for Hepatitis B and C: a French Cohort

NCT01953458 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20902

Last updated 2023-01-31

No results posted yet for this study

Summary

* The cohort will integrate clinical, genetic, pharmacogenomics, environmental, biomarkers and behavioral data in a large number of patients and will be a leading equipment for crossdisciplinary and translational research on hepatitis.
* The cohort will be the main support for estimating the relative effects of treatments and for further cost-effectiveness studies on the management and treatment options in chronic HCV (Hepatitis C Virus)and HBV (Hepatitis B virus)infections.

Conditions

  • Viral Hepatitis B
  • Viral Hepatitis C

Sponsors & Collaborators

Principal Investigators

  • Stanislas POL, MD, PhD · Hôpital Cochin, PARIS

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-06
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • France

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01953458 on ClinicalTrials.gov